Business Wire

CA-TRADESHIFT

10.2.2020 15:02:12 CET | Business Wire | Press release

Share
Tradeshift Announces Hiring of Top Talent from FinancialForce, Ariba, SAP, and Oracle

Tradeshift, the leader in supply chain payments and marketplaces, has announced the addition of four new hires hailing from Microsoft, Ariba, SAP and Oracle. On the heels of Tradeshift’s latest funding news, in which the company announced $240 million in funding, the company welcomes these seasoned veterans to help the company reach its strategic goals for 2020.

The four new hires represent deep experience in a range of business leadership initiatives including network, product and sales. The roles include:

Janet Heppner-Jones, VP of North America Sales : Heppner-Jones has an impressive background in digital solutions and SaaS sales leadership, most recently leading the America's sales team at Baker Hughes. Her diverse background has provided her with global executive responsibilities in many multinational companies across many business functions, including SAP, ABB, Dassault Systems, and Ariba. Heppner-Jones began her career as a Sales Representative with IBM where she earned the prestigious Eagle Award (top 1% of the sales force). At Tradeshift, Heppner-Jones will continue and accelerate the 60 percent growth rate, increase deal size, and work with partners in North America.

Tony Alvarez, VP of Network : Alvarez will be responsible for Tradeshift seller onboarding, GMV growth, and the Tradeshift early payment and Marketplace offerings. Prior to joining, Alvarez spent 10 years with SAP Ariba serving in several senior leadership positions in the commercial and operational functions, most recently serving as SVP of Ariba Business Network Solutions. He has experience in large deal negotiations, network monetization, and marketplace development. Alvarez began his career with Arthur Andersen Consulting, then went on to earn his MBA at Harvard.

Henry Goh, VP of APAC Sales: Goh will be leading all APAC sales as the VP of Sales, APAC. For the past 10 years, Goh has been running APAC sales for Ariba. Prior to Ariba, he was at PwC and Oracle leading teams across Asia. Goh has a wealth of experience in “go-to-market” strategy in APAC. He has experience in large deal negotiations including cultivating, developing, formulating and constructing deals.

Raphael Bres, Chief Product Officer: Bres brings to Tradeshift over 20 years experience building ERP’s at Workday, FinancialForce, and Peoplesoft, built on a solid foundation from Deloitte, Oracle and Microsoft. While Bres will be based out of our San Francisco office, he also brings strong global experience, having not only held international roles but also earning his graduate degrees from Université Paris Dauphine.

“This is a pivotal year for Tradeshift and we’re hyper-focused on the areas of the business that will give us the greatest momentum and lead us to profitability,” said Christian Lanng, CEO of Tradeshift. “With a combined 70 years of experience, Janet, Tony, Henry and Raphael will successfully lead the charge on tackling the aggressive and ambitious goals we have set out for ourselves and will no doubt make this the most successful year we’ve seen at Tradeshift.”

About Tradeshift

Tradeshift drives supply chain innovation for the digitally connected economy. As the leader in supply chain payments and marketplaces, the company helps buyers and suppliers digitize all their trade transactions, collaborate on every process, and connect with any supply chain app. More than 1.5 million companies across 190 countries trust Tradeshift to process over half a trillion USD in transaction value, making it the largest global business network for buying and selling. Discover commerce for all at tradeshift.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye